Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2010
06/10/2010CA2745509A1 Solid dosage forms of bendamustine
06/10/2010CA2745495A1 Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals
06/10/2010CA2745434A1 Dimeric avermectin and milbemycin derivatives
06/10/2010CA2745433A1 N-{[(ir,4s,6r-3-(2-pyridinylcarbonyl)-3-azabicyclo [4.1.0]hept-4-yl] methyl}-2-heteroarylamine derivatives and uses thereof
06/10/2010CA2745420A1 N-{[(ir,4s,6r-3-(2-pyridinylcarbonyl)-3-azabicyclo [4.1.0] hept-4-yl] methyl}-2-heteroarylamine derivatives and uses thereof
06/10/2010CA2745415A1 Methods for preventing or reducing carcinogenesis or oxidative stress
06/10/2010CA2745383A1 Compositions comprising renin-angiotensin aldosterone system inhibitors and lipoic acid compounds, and the use thereof for the treatment of renin-angiotensin aldosterone system related disorders
06/10/2010CA2745376A1 Methods and compositions for altering health, wellbeing, and lifespan
06/10/2010CA2745356A1 2h-chromene compound and derivative thereof
06/10/2010CA2745280A1 Phosphatidylinositol-3-kinase p110 delta-targeted drugs in the treatment of cns disorders
06/10/2010CA2745265A1 Drug composition cytotoxic for pancreatic cancer cells
06/10/2010CA2745262A1 Crystalline forms
06/10/2010CA2745252A1 Nitrate derivatives of cilostazol for the treatment of vascular and metabolic diseases
06/10/2010CA2745238A1 Pancreatic tumour treatment
06/10/2010CA2745233A1 Composition for the use to treat alzheimer's disease
06/10/2010CA2745224A1 Methods for preventing or reducing colon carcinogenesis
06/10/2010CA2745206A1 High penetration compositions and their applications
06/10/2010CA2745199A1 Treatment for glomerulonephritis with 2 - [ 4- ( -7-ethyl-5h-pyrrolo [ 2,3-b ] -pyrazin- 6 -yl) propan-2-ol
06/10/2010CA2745144A1 Benzothiazole derivatives as anticancer agents
06/10/2010CA2745121A1 Morpholinone compounds as factor ixa inhibitors
06/10/2010CA2745119A1 Inhibitors of hcv ns5a
06/10/2010CA2745101A1 Intravascular indwelling catheter lock solution containing weak acid and container containing the same
06/10/2010CA2745095A1 Nitrooxy derivatives as angiotensin ii receptor antagonists
06/10/2010CA2745073A1 Inhibition of hdac2 to promote memory
06/10/2010CA2745065A1 Compounds for treating proliferative disorders
06/10/2010CA2745041A1 2, 5-diamino-substituted pyrido [4, 3-d] pyrimidines as autotaxin inhibitors against cancer
06/10/2010CA2745019A1 Quinolone compound and pharmaceutical composition
06/10/2010CA2745015A1 Pharmaceutical agent comprising quinolone compound
06/10/2010CA2744985A1 Carboxylic acid derivative containing thiazole ring useful for the prevention or treatment of hyperlipidemia
06/10/2010CA2744962A1 Antibacterial compounds
06/10/2010CA2744960A1 Il-3 inhibitors in use for treatment of rheumatoid arthritis in an early stage
06/10/2010CA2744932A1 Nalmefene hydrochloride dihydrate
06/10/2010CA2744914A1 1-(4-(pyridin-2-yl)benzyl)imidazolidine-2,4-dione derivatives
06/10/2010CA2744800A1 Method for selectively crystallizing a z isomer of iopromide
06/10/2010CA2744713A1 Raf inhibitors and their uses
06/10/2010CA2744711A1 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
06/10/2010CA2744708A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
06/10/2010CA2744647A1 Imidazopyridine derivatives which inhibit the secretion of gastric acid
06/10/2010CA2744507A1 Pyrrolopyrazinyl urea kinase inhibitors
06/10/2010CA2744489A1 Pyridazinone derivatives
06/10/2010CA2744391A1 Inhibitors of hif-1 protein accumulation
06/10/2010CA2744300A1 1- (biphenyl-4-ylmethyl) imidazolidine-2, 4-dione derivatives and their use as cb2 receptor agonists
06/10/2010CA2744197A1 Synthesis and novel salt forms of (r)-3-((e)-2-(pyrrolidin-3-yl)vinyl)-5-(tetrahydropyran-4-yloxy)pyridine
06/10/2010CA2744093A1 Usirna complexes
06/10/2010CA2743920A1 Composition for preventing adhesion
06/10/2010CA2743864A1 Soluble guanylate cyclase activators
06/10/2010CA2743785A1 Bis[o-(14-benzoylaconine-8-yl)] esters
06/10/2010CA2743592A1 Kinase inhibitors with improved cyp safety profile
06/10/2010CA2742709A1 Novel 4- (azacycloalkyl) benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmetics
06/10/2010CA2742703A1 Novel 4- (heterocycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and also in cosmetics
06/10/2010CA2742366A1 Synthesis and novel salt forms of (r)-5-((e)-2-(pyrrolidin-3-ylvinyl)pyrimidine
06/10/2010CA2740347A1 Use of alkanoyl l-carnitine in combination with chemotherapeutic agents for the treatment of neoplasms
06/09/2010EP2194129A2 Pharmaceutical composition comprising anti-miRNA antisense oligonucleotides
06/09/2010EP2194128A1 Compositions and methods for inhibiting expression of the PCSK9 gene
06/09/2010EP2194068A1 Cyclodextrin compound modified with folic acid, process for production thereof, drug delivery agent for targeting drug delivery system, pharmaceutical composition, and imaging agent
06/09/2010EP2194058A1 Pyrazolopyrimidines suitable for the treatment of cancer diseases
06/09/2010EP2194057A1 Stable crystalline salts of 5-methyltetrahydrofolic acid
06/09/2010EP2194056A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical use
06/09/2010EP2194054A1 Ligands for G-protein coupled receptors
06/09/2010EP2194053A1 Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
06/09/2010EP2194051A1 Process for preparing compounds useful as intermediates for the preparation of modulators of chemokine receptor activity
06/09/2010EP2194049A1 N-oxides of N-phenyl-2-pyrimidine-amine derivatives
06/09/2010EP2194048A1 Nitrate esters for the treatment of vascular and metabolic diseases
06/09/2010EP2194047A1 Preparation and use of aspartyl protease inhibitors
06/09/2010EP2194046A1 Triazolone derivative
06/09/2010EP2194045A1 Substituted pyrazole derivative
06/09/2010EP2194044A1 Quinolone derivative
06/09/2010EP2194043A2 Processes and intermediates
06/09/2010EP2194041A1 Novel crystal form IX of atorvastatin hemi-calcium and processes for its preparation
06/09/2010EP2193808A1 Synergistic combination
06/09/2010EP2193806A1 Agent for promoting corneal endothelial cell adhesion
06/09/2010EP2193796A1 Use of corrinoids for the treatment of skin diseases
06/09/2010EP2193795A1 Latanoprost-containing aqueous pharmaceutical composition
06/09/2010EP2193794A1 Use of eltoprazine for the treatment of L-Dopa-induced dyskinesia
06/09/2010EP2193793A1 Nerve cell death inhibitor
06/09/2010EP2193792A1 Neomycin for increasing the survival of aquatic animals exposed to IPNV
06/09/2010EP2193791A1 The treatment of respiratory diseases
06/09/2010EP2193790A1 IL-3 Inhibitors in use for treatment of rheumatoid arthritis in an early stage
06/09/2010EP2193789A1 The application of 3, 5-dihydroxytoluene or derivatives thereof in the preparation of medicine and functional for treating or preventing depression.
06/09/2010EP2193788A1 Pharmaceutical compositions comprising colloidal silicon dioxide
06/09/2010EP2193779A1 Skin whitener
06/09/2010EP2193760A2 Hoof bath system
06/09/2010EP2193204A2 Novel lipophilic compositions and uses thereof
06/09/2010EP2193135A1 Triazole compounds that modulate hsp90 activity
06/09/2010EP2193133A2 Imidazolothiadiazoles for use as protein kinase inhibitors
06/09/2010EP2193131A2 Imidazo[1,2-a]pyrazine compounds for treatment of viral infections such as hepatitis
06/09/2010EP2193130A1 Pyrazolo-pyridines as tyrosine kinase inhibitors
06/09/2010EP2193129A1 6-pyrimidinyl-pyrimid-2-one derivative
06/09/2010EP2193127A1 Benzothiazole compounds
06/09/2010EP2193126A1 Oxadiazole diaryl compounds
06/09/2010EP2193125A2 Oxadiazole derivatives
06/09/2010EP2193124A1 Naphthalene isoxazoline compounds for control of invertebrate pests
06/09/2010EP2193123A1 Novel benzimidazol-2-yl-alkylamines and the use thereof as microbicidal agents
06/09/2010EP2193122A1 Imidazole derivatives
06/09/2010EP2193121A1 Quinolin-4-one and 4-oxodihydrocinnoline derivatives as inhibitors of poly(adp-ribose)polymerase (parp)
06/09/2010EP2193119A1 4-(4-pyridinyl)-benzamides and their use as rock activity modulators
06/09/2010EP2193118A2 Piperidine and piperazine derivatives for treating tumours
06/09/2010EP2193117A1 Inhibitors of beta amyloid production
06/09/2010EP2192919A1 Methods of inhibiting tumor growth using beta 5 integrin antagonists
06/09/2010EP2192906A2 Delayed self-gelling alginate systems and uses thereof
1 ... 2231 2232 2233 2234 2235 2236 2237 2238 2239 2240 2241 2242 2243 2244 2245 2246 2247 2248 2249 2250 2251 ... 7860